Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 22 Jun 2022 for Day One Biopharmaceuticals, Inc., €10.9M.
Filing timeline
BuySaleMichael Gladstone
Insider track record
Disclosed buys
1
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+2.9%
Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
No signal scores available.
Michael Gladstone: trading record in brief
Michael Gladstone has a single filing on record, published on 22 June 2022: an open-market purchase of €10.9M in Day One Biopharmaceuticals, Inc. One trade is not enough to describe a pattern. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Michael Gladstone
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations1 total
- 766,667 shares@ US$15.001.14% mcap100.0% of flowCommon StockSEC:0001209191-22-038696:0Canonical exit: 15 Sept 2022 (T+90)
1 of 1 declaration
